SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Audre Lorde

PatientAudre Lorde
Date of birth1981-02-18
IdentifiersMRN HR-ML016-SYN; SSN (made up) 000-16-2937
Document date2026-10-19
AuthorNaomi Fairweather, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Adult preventive visit; no new complaints. [S]

History of Present Illness

Ms. Lorde comes for her yearly preventive visit, three weeks after her one-year survivorship visit. She is thirteen months from a right mastectomy for stage IA hormone receptor-positive breast cancer and has taken tamoxifen daily for a year. Her left mammogram four weeks ago was normal. She saw the genetic counselor two weeks ago, and the panel result is expected in about two weeks. Her hot flashes are mild and settled with the cooling measures she has used since the spring. Her periods come every 28 to 35 days and are lighter than before tamoxifen, with no bleeding between periods. She walks most days and is writing well. She completed the health risk assessment before the visit. [S]

ElementDetail
VisitAdult preventive visit, age 45
Active conditionsStage IA right breast cancer after mastectomy, on adjuvant tamoxifen
MedicinesTamoxifen 20 mg daily
GynecologicCycles every 28 to 35 days, lighter; no intermenstrual or postcoital bleeding
Functional statusIndependent; walking about 200 minutes a week

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood
PsychosocialClose family and a wide circle of friends and fellow writers; no financial strain; feels safe at home
BehavioralNever smoker; a glass of wine a few times a month; walks most days; cooks most meals with vegetables and whole grains
Activities of daily livingIndependent in all
Instrumental activities of daily livingManages her own medicines, money, travel, and household
Home safetySmoke detectors working; wears a seat belt; no firearms in the home
Hearing and visionReading glasses; eye examination last year; no hearing concern
SleepAbout seven hours a night; hot flashes wake her about once a week

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight stable; no fever, night sweats, or unexplained tiredness
EyesNegativeNo change in vision; no floaters
Ears, nose, mouth, and throatNegativeNo hearing change or mouth sores
CardiovascularNegativeNo chest pain, palpitations, or leg swelling
RespiratoryNegativeNo cough or breathlessness
BreastNegativeNo lump, pain, or skin change in the left breast or on the right chest wall
GastrointestinalNegativeRegular bowels; no blood in the stool
GenitourinaryNegativeNo abnormal vaginal bleeding, discharge, or pelvic pain; no urinary symptoms
MusculoskeletalNegativeNo bone pain; full use of the right arm
IntegumentaryNegativeMastectomy scar comfortable; no new skin lesions
NeurologicalNegativeNo headaches or numbness
PsychiatricNegativeMood good; PHQ-2 score 0
EndocrinePositiveMild hot flashes, one or two a day; one wakes her about once a week

13 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Tamoxifen 20 mg oral tablet, one tablet by mouth once daily, planned for at least five yearsOne tablet once dailyOral route2025-10-27activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-19Body height168cmS
2026-10-19Body weight71.5kgS
2026-10-19Body mass index (BMI) [Ratio]25.3kg/m2S
2026-10-19Systolic blood pressure118mm[Hg]S
2026-10-19Diastolic blood pressure74mm[Hg]S
2026-10-19Heart rate70/minS
2026-10-19Respiratory rate14/minS
2026-10-19Body temperature36.6CelS
2026-10-19Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-19Cholesterol [Mass/volume] in Serum or Plasma182mg/dL<=199 mg/dLNormalS
2026-10-19Cholesterol in HDL [Mass/volume] in Serum or Plasma64mg/dL>=50 mg/dLNormalS
2026-10-19Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation98mg/dL<=99 mg/dLNormalS
2026-10-19Triglyceride [Mass/volume] in Serum or Plasma100mg/dL<=149 mg/dLNormalS
2026-10-19Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS
2026-10-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-10-19Total score [AUDIT-C]1{score}S

Physical Exam

Vital signs recorded on 2026-10-19; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell-appearing; BMI 25.3
EyesPupils equal and reactive; conjunctivae normal
Ears, nose, and throatNormal
NeckNo thyroid enlargement; no cervical or supraclavicular nodes
CardiovascularRegular rhythm; no murmur; no edema; calves soft and non-tender
RespiratoryClear
Breasts and chest wallRight chest wall flat with a healed transverse scar; no nodules or skin change. Left breast without masses, skin change, or nipple discharge
Lymph nodesNo axillary, supraclavicular, or cervical nodes
ExtremitiesArms equal in size; right shoulder full range of motion
AbdomenSoft; no masses; liver not enlarged
PelvicExternal genitalia, vagina, and cervix normal; no blood in the vault; cervical sample taken; uterus normal size; no adnexal masses
SkinNo suspicious lesions
PsychiatricEngaged, warm, and direct

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the upper outer quadrant of the right breast, stage IA (pT1c pN0(sn) M0), grade 2, estrogen and progesterone receptor positive, HER2 negative, recurrence score 14; treated by right total mastectomy with sentinel node biopsy and on adjuvant tamoxifen; synthetic modern counterpart of the documented 1978 breast cancer and mastectomyactiveconfirmed C50.411S — Synthetic tumor details and treatment; the diagnosis and the mastectomy are documented (D), but no tumor details from her lifetime are used.
Estrogen receptor positive status of the breast cancer (ER 90 percent, PR 60 percent)activeconfirmed Z17.0S — Synthetic receptor result; no receptor status from her lifetime is known.
Absence of the right breast after mastectomy with flat closure; she chose not to have reconstruction and not to wear an external prosthesisactiveconfirmed Z90.11S — Synthetic coding of the documented mastectomy; the decision about a prosthesis echoes her documented choice and is respected as her own.
Long-term use of tamoxifen as adjuvant endocrine therapyactiveconfirmed Z79.810S — Synthetic treatment status.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, 2026-2027Completed todayInactivated vaccine given today
COVID-19 vaccine, 2026-2027DueRecommended; she will get it at her pharmacy
Hepatitis B vaccineDueRecommended for adults 19 to 59; series to start at the January visit if the screening test shows no immunity
Tetanus boosterUp to dateTdap seven and a half years ago; next due in about two and a half years
Zoster and pneumococcal vaccinesNot indicatedRecommended from age 50; tamoxifen is not immunosuppressive
Breast cancer screeningNot indicatedReplaced by surveillance: yearly diagnostic mammogram of the left breast, last done four weeks ago
Cervical cancer screeningCompleted todayCytology with HPV co-testing; last screening more than five years ago; result pending
Colorectal cancer screeningOrderedRecommended from 45; after discussing the options she chose a yearly fecal immunochemical test; kit given
Hepatitis B, hepatitis C, and HIV screeningOrderedOne-time screening; no prior result on record; drawn today, results pending
Cholesterol screening and statin decisionCompleted todayLDL 98 mg/dL; low 10-year risk; no statin
Diabetes screeningCompleted todayHbA1c 5.4% (BMI 25.3)
Blood pressure screeningCompleted today118/74 mmHg
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C 1, negative
Intimate partner violence screeningCompleted todayNegative; feels safe at home
Tobacco useCompleted todayNever smoker
Bone density testingNot indicatedPremenopausal on tamoxifen alone; calcium and vitamin D from diet and weight-bearing exercise advised
Physical activity and diet counselingCompleted todayWalking about 200 minutes a week; add strength exercise twice a week

Immunizations given today: Influenza vaccine, 2026-2027 season [S]

Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Cervical screening, hepatitis B, hepatitis C, and HIV results by portal message. Fecal immunochemical test returned by mail. Survivorship visit in January with the genetic panel result. Next preventive visit in one year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 16 minutes, with her consent. She has named a health care agent, and a written health care directive form was given for her to complete at home. She wants complete and frank information about her health and to make her own decisions. No specific treatment preferences were recorded today; the discussion will continue at next year's visit or sooner if her health changes. [S]